Post My Press Release

Free Press Release Distribution

Category: healthcare (Page 1 of 1056)

Pyrogen Testing Market Revenue Is expected To Reach USD 1.9 Billion By 2025: Grand View Research Inc.

San Francisco, 12 June 2019: The Report Pyrogen Testing Market Analysis By Product (Instruments, Consumables, Services), By Test Type (LAL Test, In Vitro Pyrogen Test, Rabbit Test), By End Use (Pharma, Biotech & Medical Devices Companies), & Segment Forecasts, 2018 – 2025

The global pyrogen testing market is expected to reach a value of USD 1.9 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for therapeutic drugs including pharmaceuticals, biopharmaceuticals, and biologics is the major factor that propels growth of the market during forecast period. Pyrogen is a toxic molecular substance that causes fever if induced in animal or human body. Pyrogen testing is used by pharmaceutical, biopharmaceuticals, biotechnology, and medical devices companies to confirm the absence of pyrogen. Thus, the companies use various methods such as LAL, in vitro pyrogen, and rabbit test to ensure the quality of products.

Increasing prevalence of chronic diseases, is another foremost factor supporting the growth of the pyrogen testing market. The prevalence of chronic diseases is very high in developed countries and is growing at high pace in developing countries including China and India. Different factors such as unhealthy diet, smoking, alcohol consumption, and lack of exercise leads to occurrence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases.  Hence, there is a growing demand for therapeutic drugs and medical devices for the treatment of such diseases, which in turn is projected to fuel the demand for pyrogen testing to ensure the quality of products including drugs and devices.

Access Research Report of Pyrogen Testing Market @ www.grandviewresearch.com/industry-analysis/pyrogen-testing-market

Further key findings from the study suggest:

  • Consumables was the largest revenue grossing segment of the pyrogen testing market in 2016, owing to the large application of pyrogen testing kits and reagents along with its repetitive purchase
  • Instruments segment accounted for the remarkable share in the market in 2016 and is also expected to showcase significant growth during forecast period, owing to rising demand for pharmaceutical, biologics, and medical devices for treatment and diagnosis
  • The pharmaceutical and biotechnology companies segment dominated the pyrogen testing market in terms of revenue in 2016, due to the large production of therapeutic drugs and growing investment in R&D by companies for drug development
  • North America is the leading regional market and accounted for the largest revenue share in 2016 primarily due to the existence of large number of healthcare companies including pharmaceuticals and medical devices in this region
  • The Asia Pacific region is anticipated to be the fastest growing market during the study period. The growing prevalence rate of chronic diseases in the Asian countries including India and China, is a major factor contributing to the expansion of market in this region.
  • Some major players serving this vertical include Charles River Laboratories, Inc.; Ellab A/S; Merck KGaA; GenScript; Hyglos GmbH; Lonza; Thermo Fisher Scientific, Inc.; Associates of Cape Cod, Inc.; and Pyrostar

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the pyrogen testing market on the basis of product, test type, end-use, and region:

Pyrogen Testing Product Outlook (Revenue, USD Million; 2014 – 2025)

  • Consumables
  • Instruments
  • Services

Pyrogen Testing Test Type Outlook (Revenue, USD Million; 2014 – 2025)

  • LAL test
  • Chromogenic test
  • Turbidimetric test
  • Gel clot test
  • In vitro pyrogen test         
  • Rabbit test

Pyrogen Testing End-Use Outlook (Revenue, USD Million; 2014 – 2025)

  • Pharmaceutical and biotechnology companies
  • Medical devices companies
  • Others

Pyrogen Testing Regional Outlook (Revenue, USD Million; 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Pyrogen Testing Market@ www.grandviewresearch.com/press-release/global-pyrogen-testing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Mass Spectrometry Market | Key Growth Factors Analysis

The overall mass spectrometry market is expected to grow from USD 3.44 billion in 2016 to USD 5.27 billion by 2022, at a CAGR of 7.4%.

Mass spectrometry is an analytical technique used to measure known materials, to identify unknown compounds within a sample, and to evaluate the structure and chemical properties of different molecules. The technique ionizes chemical species and sorts the ions, based on their mass-to-charge ratio. Because of the high sensitivity of these techniques, mass spectroscopy has become a powerful analytical tool for testing in various industries.

The Research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Mass Spectrometry Market, along with revenue estimates & forecasts and market share analysis.

Moreover, the study showcases back-to-back parameters like application, improvement, product growth, and diverse structures & key processes. The report highlights the in-depth analysis of various critical parameters such as profit & loss statistics, product value, production capability, production process, and many more.

Factors such as technological advancements in mass spectrometry, government initiatives for pollution control and environmental testing, increasing spending on pharmaceutical R&D across the globe, growing petrochemical industry, and growing focus on ensuring the quality of food products are expected to drive the growth of this market.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=437


Mass Spectrometry Market Segmentation:

1. By Platform
2. By Application
3. By Region

The Major Players Opearting in the Mass Spectrometry Market:

Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), and SCIEX (Subsidiary of Danaher) (US) are the key players in the mass spectrometry market.

Sciex under Danaher Corporation (US) dominated the mass spectrometry market in 2016. The company provides a wide range of mass spectrometry technologies, accessories, and software in the mass spectrometry market. These products find application in a range of industries including pharmaceuticals, environmental agencies, food & beverage, petroleum industry, and research laboratories. To maintain its leading position and increase its customer base in the mass spectrometry market, the company mainly focuses on expanding its market presence by enhancing its product development capabilities and product launches & enhancements.

Geographical Analysis Of Mass Spectrometry Market:

The mass spectrometry market in North America is expected to grow at the highest CAGR during the forecast period. North America is the fastest-growing market for mass spectrometry. The key factors influencing the growth of this market include the growing funding for environmental testing in the US, widespread usage of mass spectrometry in the pharmaceutical sector, growing food safety concerns in the US, and government initiatives to improve lab infrastructure and propel fundamental scientific research in Canada.

Read more: https://www.marketsandmarkets.com/PressReleases/mass-spectrometry-market.asp

Smart Inhalers Market To 2016 : Top Industry Players, Revenue By 2024

Smart Inhalers Market: Overview

Smart inhalers, also known as connected inhalers and sensors are predominantly used as clip-on sensors, which are fastened on top of a regular nebulizer for the treatment of chronic obstructive pulmonary disorder (COPD) and asthma. Smart inhaler technology is birthing as one of the most notable areas that pharmaceutical companies are engaged in order to push digital health. Smart inhalers help patients keep track of dosage of relievers or preventers that are administered at various intervals during the day. These smart devices can raise reminders and alerts for users based on previous pattern of dosage administration or based on inputs fed by users.

View Report: https://www.transparencymarketresearch.com/smart-inhalers-market.html

Smart Inhalers Market: Key Trends

The growth of the smart inhalers market is attributed to increasing air pollution, increasing incidence of respiratory diseases such as COPD and asthma, and burden on healthcare services due to higher cases of COPD and asthma. In addition, increasing adoption of smart inhalers for proper management of COPD and asthma are further boosting the market’s growth.

Top pharmaceutical companies are adopting digital technology in their way for improved disease management such as that for asthma and COPD and for improving the efficacy of prescribed medicines. Extensive benefits that range from reducing hospital admissions to improving the efficacy of medicines, makes smart inhalers the talk of the town in the respiratory care segment.

However, high costs involved in the treatment of COPD and asthma due to their chronic nature, limited availability of smart inhalers, and misinterpretation of information are expected to challenge the market’s growth.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=21014

Smart Inhalers Market: Market Potential

The efficacy and ability for the smart management of respiratory diseases has called in for smart inhalers to enter the U.K healthcare system, as per a recent industry news. The impending entry of smart inhalers in the National Health Service (NHS) might herald the onset of the smart healthcare age. However, proper planning and rigorous testing is needed before smart inhalers ensure smart-enabled healthcare delivers best outcomes for individuals with asthma, adds the NHS.

Smart Inhalers Market: Regional Outlook

On the regional perspective, Europe has emerged as the second largest market for smart inhalers. This is because smart inhalers are increasingly being adopted in hospitals and physicians’ offices, thereby boosting the market growth. The European Academy of Allergy & Clinical Immunology is continuously striving to increase awareness about COPD and asthma and the use of technology for smart management of these conditions.

North America stood as the largest revenue generator for the market in the recent past, whereas Asia Pacific is expected to rise at a double-digit growth rate over the next few years. Asia Pacific has vast untapped opportunities in the smart inhalers market as it has a growing population base combined with rising disposable incomes and increasing awareness about the use of digital devices for proper disease management.

Smart Inhalers Market: Competitive Landscape

Some important players in the smart inhalers market include Teva Pharmaceuticals Industries Ltd., Vectura Group plc, AstraZeneca plc, Propeller Health, Adherium Limited, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Cohero Health LLC, OPKO Health Inc., and Novartis AG.

Request TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=21014

Of these, Adherium is a key player in the market with majority of product approvals to its credit. Because smart inhalers is a lucrative market, collaborations and acquisitions between pharmaceutical companies, smart inhaler manufacturers, and medical device companies is on the rise for larger market share. Key players in the smart inhalers market are also focused on product approval and clinical trials to stay competitive in this market.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Preimplantation Genetic Diagnosis Market 2023 Growth Analysis By Manufacturers, Regions, Type And Application, Forecast Analysis

Rising numbers of assisted reproductive procedures such as in vitro fertilization (IVF) is Asia is the most prominent factor driving the market for preimplantation genetic diagnosis. This is, in essence, the result of factors such as the delayed age of conception among Asian women, the rising rate of infertility among the population, and the significantly expanding medical tourism industry in the region. Rising disposable incomes and increased awareness regarding the rising prevalence of a number of genetic disorders are also encouraging the Asian population to undertake costly diagnostic procedures such as PGD.

View Report: https://www.transparencymarketresearch.com/asia-preimplantation-genetic-diagnosis-market.html

TMR analysts project that these factors will enable the Asia preimplantation genetic diagnosis market expansion at a healthy 6.8% CAGR from 2015 to 2023. The market is expected to rise from a valuation of US$16.0 mn in 2014 to US$28.8 mn by 2023.

Rising Preference for Single Gene Disorder Screening over Prenatal Diagnostic Testing to Drive Market

Preimplantation genetic diagnosis for the screening of aneuploidy held the largest share of 34.7% in the Asia PGD market in 2014. Liberal regulations pertaining to this area of diagnosis in most Asian countries is the major factor behind the high numbers of aneuploidy screening tests undertaken every year in the region. However, PGD for single gene disorder is projected to expand at the faster CAGR of 8.4% from the period between 2015 and 2023.

Increased preference of this diagnostic modality is encouraged by technological advancements and relatively high accuracy of results. Moreover, single gene disorder screening is more beneficial compared to conventional prenatal diagnostic testing in embryo, driving the market for PGD for single gene disorder.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9989

Rising Numbers of Healthcare Facilities to Boost Asia PGD Market

Known to provide excellent medical services at highly economical rates as compared to developed regions, the healthcare industry in Asia has invited patients from world over. With continuous advancements in healthcare infrastructure, rising numbers of healthcare experts, and constantly improving diagnostic facilities, Asia is expected to be a major hub for the PGD market in the future. Many global vendors in the healthcare and diagnostics industry are extending their businesses in the region and the number of fertility clinics, hospitals, and diagnostic centers are constantly rising in the region.

Fertility clinics held a major share in the overall Asia PGD market in 2014, and are expected to exhibit a 5.9% CAGR from the period between 2015 and 2023. However, the segment of healthcare facilities is expected to expand at a much better 7.8% CAGR over the same period. The flourishing tourism industry in the region is leading to the establishment of an increasing number of IVF centers and healthcare facilities such as hospitals and diagnostic centers in the region.

Request a Sample of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=9989

Asia PGD Market to Witness Highest Traction in Southern Countries

In the next few years, the Asia PGD market is expected to witness the highest growth in Southern countries such as India and China. The high and rising rate of infertility in South Asian countries, rising disposable incomes, high percentage of women in the workforce, and availability of technologically advanced healthcare infrastructure will enable the region in presenting the most attractive growth opportunities for the Asia PGD market. Countries in Southern Asia will also benefit from the flourishing medical tourism industry during the period between 2015 and 2023.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Global Regenerative Medicine Market Outlook 2025

Bharat Book Bureau Provides the Trending Market Research Report on “Global Regenerative Medicine Market [By Technology – Cell Therapy, Tissue Engineering & Gene Therapy; By Region – North America (The US), Europe (The UK) & Asia Pacific (Japan) Market Outlook 2025” under Healthcare category. The report offers a collection of superior market research, market analysis, competitive intelligence and industry reports.

Regenerative Medicine is an interdisciplinary field of medicine which has ability to transform human medicine. It repairs or regenerates damaged or diseased human cells, tissues or organs in order to restore normal functionality of the body. It stimulates the body’s own repair mechanisms to heal tissues or organs. Regenerative medicine has emerged as pertinent treatment choice for treatment of various degenerative disorders as well as for restoration of functions of tissues and cells in other therapies. It is used for treatment of various chronic and acute cardiovascular diseases, dermal wounds, neurodegenerative diseases, orthopedic applications and in treatment of certain types of cancer. 

Request a free sample copy of Regenerative Medicine Market Report @ https://www.bharatbook.com/marketreports/sample/reports/1563959

Regenerative medicines are principally based upon four therapies – Cell Therapy, Tissue Engineering, Small Molecules and Gene Therapy. Cell Therapy enjoys highest popularity, accounting for more than half of the share of the market. Global regenerative medicine market has been witnessing significant growth over past several years. Growth of the market is attributed to prevalence of chronic diseases, rise in number of trauma cases, organ shortages, increasing incidence of cancer, growing geriatric population and increasing R&D investment. However, some of the growth impediments of the market includes expensive treatment cost and stringent regulatory compliance.

The report “Global Regenerative Medicine Market [By Technology – Cell Therapy, Tissue Engineering & Gene Therapy; By Region – North America (The US), Europe (The UK) & Asia Pacific (Japan) Market Outlook 2025” provides in-depth analysis of the current scenario, detailed market outlook of the global regenerative medicine market with market segmentation done across major technologies and across major markets in North America, Europe and Asia Pacific region. Future forecasts of regenerative medicine market overall and across various regional markets has been provided in the report till 2025. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global regenerative medicine market include Integra LifeSciences Corporation, Merck & Co., Inc., Stryker Corporation, Organogenesis Inc., Vericell Corporation, MiMedx Group, Inc., among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global regenerative medicine market.

Browse our full report with Table of Contents : https://www.bharatbook.com/marketreports/global-regenerative-medicine-market-by-technology-cell-therapy-tissue-engineering-gene-therapy-by-region-north-/1563959

About Bharat Book Bureau:

Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Industry Trends & Analysis, Forecasts & Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:

Bharat Book Bureau

Tel: +91 22 27810772 / 27810773

Email: poonam@bharatbook.com

Website: www.bharatbook.com

Follow us on : Twitter, Facebook, LinkedIn



Healthcare Information Systems Market Technology That Supports Real-Time Patient Monitoring In 2018 To 2025 : Grand View Research Inc.

San Francisco, 12 June 2019: The Report Healthcare Information Systems Market Analysis Report By Application, By Deployment (Web-based, Cloud-based), By Component, By End Use (Hospitals, Diagnostic Centers), And Segment Forecasts, 2018 – 2025

The global healthcare information systems market size is expected to reach USD 169.2billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.7% CAGR during the forecast period. The market is majorly driven by increase in adoption of advanced technologies in healthcare facilities. Growing usage of digital healthcare infrastructure, which helps in collecting and managing information generated by hospitals, clinics, and institutes, has enhanced efficiency and effectiveness of their services. Furthermore, increase in number of patients suffering from chronic diseases and rising demand for cloud-based systems are expected to boost the market in the forecast period.

Potential opportunities of IT in healthcare in applications such as reducing operating costs incurred while record keeping and meeting regulatory standards for privacy, as well as efficient hospital workflow management, are among other factors driving uptake. Furthermore, it is expected that these systems will, in the long run, save money and allow organizations to earn significant profits.

Growing demand for radiology information systems in diagnostic procedures has propelled the healthcare information systems market. The sophisticated database system allows medical professionals to track massive image files produced during the course of diagnosis and treatment.

Access Research Report of Healthcare Information Systems Market @ www.grandviewresearch.com/industry-analysis/healthcare-information-system-market

Further key findings from the report suggest:

  • In 2016, hospital information system held the largest share by application owing to increase in adoption in hospitals for improving operational efficiency
  • By deployment, cloud-based systems are expected to grow at a faster pace over the forecast period. Utilization of cloud-based technology has increased due to various security breaches in on-premise and web-based deployment solutions
  • On the basis of component, services held the largest share in 2016. With advancements in software and hardware, the demand for these services is expected to increase
  • In 2016, hospitals emerged as the largest end-use segment. The shift in trend from volume-based care to value-based care is leading to increase in demand for information systems in hospitals
  • North America was a major contributor to the healthcare information systems market in 2016
  • Key players in this space include McKesson Corporation; Cerner Corporation; Athenahealth, Inc.; Allscripts; Medidata Solutions Inc.; GE Healthcare; Siemens Healthineers; and NextGen Healthcare.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global healthcare information systems market on the basis of application, deployment, component, end use, and region:

Healthcare Information Systems Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Hospital Information Systems
    • Electronic health record
    • Electronic medical record
    • Real-time healthcare
    • Patient engagement solution
    • Population health management
  • Pharmacy Information Systems
    • Prescription management
    • Automated dispensing systems
    • Inventory management
    • Others
  • Radiology information systems
  • Monitoring analysis software
  • Picture archiving and communication system
    • Laboratory Information Systems
    • Revenue Cycle Management
    • Medical Imaging Information System

Healthcare Information Systems Deployment Outlook (Revenue, USD Million, 2014 – 2025)

  • Web-based
  • On-premise
  • Cloud base

Healthcare Information Systems Component Outlook (Revenue, USD Million, 2014 – 2025)

  • Hardware
  • Software and systems
  • Services

Healthcare Information Systems End-use Outlook (Revenue, USD Million, 2014 – 2025)

  • Hospitals
  • Diagnostic centers
  • Academic and research institutes

Healthcare Information Systems Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Healthcare Information Systems Market @ www.grandviewresearch.com/press-release/global-healthcare-information-system-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Blood Collection and Transfusion Devices Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

The global blood collection and transfusion devices market is poised to value over $8 billion by 2026 end with an impressive CAGR of 5.3% during the forecast period 2019-2026.

Rise in the number of trauma cases, increase in the number of surgical procedures, rising blood disorders like cancer, aplastic anaemia, sickle cell anaemia, an ageing population, etc. Advancement in technology, feasible blood transfusion devices, is few of the factors facilitating the easy blood transfusion when extremely required. 
Due to all the above factors, blood collection and transfusion devices market is flourishing at stead-fast speed in both developed and developing economies. Additionally, the strict regulatory norms are shaping the robust growth patterns of this market.

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=71&page=requestsample

Global Blood Collection and Transfusion Devices Market, by Product Type
•    Blood Collection Tubes 
•    Needles & Syringes
•    Vacuum Blood Collection System
•    Non-vacuum Blood Collection System 
•    Microfluidic devices 
•    Blood collection & Storage Bags 

Global Blood Collection and Transfusion Devices Market, by Blood Component 
•    Whole Blood
•    Plasma
•    RBC
•    Others 

The whole blood is rarely used in direct medical treatments as patients may only need components like plasma, platelets, or red blood cells for recovery from surgery/casualties and chronic diseases. As stated by the Red Cross, approximately 36,000 units of red blood cells, nearly 7,000 units of platelets and 10,000 units of plasma are needed every day in the U.S. alone. Hence the focus would be on providing red blood cells and plasma to cater to the over-scrupulous demand. 
Approvals required for blood component separation and rapid use of minimally invasive technology that merely relies on blood transfusion are major restraints expected to limit to the blood collection and transfusion devices market growth.

Global Blood Collection and Transfusion Devices Market, by End-User
•    Hospitals
•    Blood Banks
•    Cord Blood Banks
•    Medical Institutes
•    Community Health Centres
•    Clinics
•    Ambulatory Centres


Blood Banks are the dominant segment when it comes to end-users of global blood collection and transfusion devices market. The rise in automation of blood banks and an increase in the number of blood banks worldwide is expected to positively stimulate the blood collection and transfusion devices market in the near future. Hospitals rank at second place in terms of the whole market share and are expected to grow at attractive CAGR for years to come.

Global Blood Collection and Transfusion Devices Market, by Region:  
•    Europe  
•    North America  
•    APAC  
•    Latin America 
•    Rest of World 

Purchase a Copy of this Premium Research Report At: https://www.futurewiseresearch.com/healthcare-market-research/Blood-Collection-and/71

Competitive Landscape:  
•    Tier 1 players- established companies in the market with a major market share  
•    Tier 2 players 
•    Emerging players which are growing rapidly 
•    New Entrants   

FutureWise Takeaways: 
•    Growth prospects  
•    SWOT analysis 
•    Key trends 
•    Key data-points affecting market growth
 
Objectives of the Study:
•    To provide with an exhaustive analysis on the global blood collection and transfusion devices market, by blood component type, by product type, by end-user, and region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) 
•    To evaluate and forecast micro-markets and the overall market  
•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East 
•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Inquire further details about this report at: sales@futurewiseresearch.com

About FutureWise Research:

We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:

Company Name: FutureWise Research
Contact Person:  Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City:  Leeds
Country:  United Kingdom
Website: www.futurewiseresearch.com

Medical Image Management Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

In the quest to cut down the barriers across provider networks and optimize the patient experience in terms of fewer scans, shorter patient wait time, online consulting solution services, etc medical image management solution emerged. They are thoroughly secure and provide a robust solution to image archiving, radiology, report dictation, study and report storage.

The technological advancements in image management solutions and willingness to invest in image management systems by an array of varied sized hospitals/imaging centres has promoted the overall growth of the medical image management market. The market is expected to register at the CAGR of 7.6% during the forecast period (2019-2026) with an increase in market values from $3.04 billion in 2018 to over $5 billion by the end of 2026 end. Factors such as technological innovations, developments in software, government initiatives are fuelling a considerable hike in the usage of medical image management systems. The entire medical image management market can be segmented on the basis of product type, mode of delivery, geography and end-users.

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=106&page=requestsample

Product Type:

The product type or solutions that are available in the market include:

•    PACS (Picture Archive and Communication System)

•    VNA (Vendor Neutral Archive)

•    AICA (Application-Independent Clinical Archive)

•    Others

PACS is widely popular in the radiology department and soon penetrating into cardiology, ophthalmology, oncology, endoscopy, dermatology, pathology, neurology, and dentistry. Owing to the increased use of PACS across various healthcare solutions, PACS dominated the market in 2018. The enterprise PACS segment is forecasted to witness the highest market growth during the forecast period. AICA is in the spotlight too due to its easy interfacing with EHRs, quick view and easy access to data, reduced storage costs, reduced migration costs, enhanced image sharing, synchronized cross-departmental workflow, enhanced business continuity and non-image data sharing. Cloud-based solutions and integration of PACS /VNA with digital medical record create tremendous opportunities for players across the industry. The key factors hampering the growth of the global market include budgetary constraints, longer product lifecycle of VNAs, usability and user interface challenges.

Purchase a Copy of this Premium Research Report At: https://www.futurewiseresearch.com/healthcare-market-research/Medical-Image-Management/106

Mode of Delivery:

Medical images are achieved electronically with the help of Medical image management systems capable of collecting, organising and controlling medical imaging data in healthcare systems with various other patient information. Cloud computing benefits range from data back-up and disaster recovery, economies of scale, scalability, flexibility, minimum upfront costs to lower maintenance costs. The multifold rise of BigData coupled with the use of artificial intelligence opened doors for convenient medical diagnostic delivery mode on cloud and hybrid environments.

Geography:

The geographic regions include:

•    North America

•    Europe

•    APAC

•    Rest of the World (RoW)

The largest share of the global medical image management market is taken up by North America, then by Europe and lastly by Asia-Pacific. Factors driving the adoption of medical image management and the dominance of North America are:

•    a large number of imaging centres in this region

•    ongoing research activities

•    the rapid adoption of technologically advanced imaging systems

•    government initiatives towards digitization, increasing adoption of EHR/EMR

Asia-Pacific is expected to witness significant growth due to emerging economies and rise in medical requirements by population dwelling in this region.

End Users:

Hospitals, Imaging Centres, diagnostic labs, Academic institutions and research organisations are main end users. Hospital leads the crowd due to the higher number of patients being treated, ease of access to patient information and of course rise in a number of hospitals due to increasing population.

Key Takeaways:

•    Identification of the high growth market segments in terms of product, delivery models, end-users, and region/countries

•    The market forecasts and estimates for the period 2019-2026

•    Major drivers, opportunities, and challenges in the medical image management market

•    The recent developments in the medical image management market

•    Factors to be considered by the major players in the global medical image management market

•    Regional trends and high growth countries

Inquire further details about this report at: sales@futurewiseresearch.com

About FutureWise Research:

We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:

Company Name: FutureWise Research
Contact Person:  Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City:  Leeds
Country:  United Kingdom
Website: www.futurewiseresearch.com

Page 1 of 1056

Powered by WordPress & Theme by Anders Norén